La Française des Jeux SA, France’s national lottery and leading betting and gaming operator, has announced a recommended public offer to the shareholders of Kindred Group plc regarding the SDRs in Kindred Group plc that are admitted to trading on Nasdaq Stockholm. Through the transaction, La Française des Jeux SA strengthens its position in Europe within gambling and betting.
Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with its partial tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
In total, sustainable capital securities with an aggregate nominal amount of SEK 370 million were repurchased. Payment for repurchased sustainable capital securities was made by way of set-off against new newly issued series B shares of the company.
Vinge advises Precio Fishbone AB (publ) (”Precio Fishbone”) in connection with the sale of approximately 80.1 per cent of the shares in the subsidiary Precio Fishbone Systems AB ("Omnia"), including the product Omnia Digital Workplace, to Monterro.
Vinge has assisted Tobii AB in connection with the acquisition of the AutoSense business from Xperi Inc. The transaction accelerates Tobii’s path to leadership in the Automotive Interior Sensing market by combining the capabilities of Tobii and AutoSense.
Vinge advises Cantargia AB (publ) in connection with a directed share issue of approximately SEK 59 million to a number of Swedish and international investors.
On 27 October 2023, Norvik hf announced, through the wholly-owned subsidiary Kivron AB, a public takeover offer to the shareholders of Bergs Timber AB (publ) to acquire all shares in Bergs Timber.
Vinge has advised Thermo Fisher Scientific Inc., (”Thermo Fisher”), the world leader in serving science, with annual revenue over $40 billion, in connection with its acquisition of Olink Holding AB (publ) (“Olink”).
Vinge is advising Studentbostäder i Norden AB (publ), a real estate company whose shares are listed on Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue amounting to a total of SEK 331 million before deduction of transaction costs and the amendments to the terms and conditions of the company’s outstanding green 2021/2024 notes with ISIN SE0015960802 (the “Notes”) by way of a written procedure.
Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), an innovative and integrated pharmaceutical company focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment, listed on Nasdaq Stockholm, in connection with a combined financing comprising a SEK 172 million equity private placement and a SEK 290 million debt financing.
A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
Vinge has advised Flat Capital in connection with its rights issue, which provides Flat Capital with proceeds of approximately SEK 153 million before deduction of transaction costs.
